156 related articles for article (PubMed ID: 35972062)
1. Severe hypoglycemia in propranolol treatment for infantile hemangiomas.
Morimoto A; Ozeki M; Sasaki S; Baba N; Kuwano Y; Kaneko T
Pediatr Int; 2022 Jan; 64(1):e15278. PubMed ID: 35972062
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
Breur JM; de Graaf M; Breugem CC; Pasmans SG
Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
[TBL] [Abstract][Full Text] [Related]
4. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
5. Deep coma in a child treated with propranolol for infantile hemangioma.
Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
[TBL] [Abstract][Full Text] [Related]
6. Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects.
Twist J; Chen A; Poffenberger P; Zinn Z
Pediatr Dermatol; 2022 Mar; 39(2):273-274. PubMed ID: 35178766
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
Miyazaki T; Ozeki M; Sasai H; Ohnishi H
Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
[No Abstract] [Full Text] [Related]
8. Propranolol induced hypoglycemia.
Horev A; Haim A; Zvulunov A
Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
10. Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population.
Fu R; Zou Y; Wu Z; Jin P; Cheng J; Bai H; Huang M; Huan X; Yuan H
Sci Rep; 2023 Apr; 13(1):5956. PubMed ID: 37046020
[TBL] [Abstract][Full Text] [Related]
11. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
Chakhunashvili K; Kvirkvelia E; Todua N; Chakhunashvili DG
BMC Pediatr; 2024 Feb; 24(1):138. PubMed ID: 38395819
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
13. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
14. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
[TBL] [Abstract][Full Text] [Related]
17. The impact of propranolol on the growth and development of children with proliferative infantile hemangioma during treatment.
Lin X; Wang T; Liu C; Deng L; Wang Q; Huang L; Gao J; Chen X; Chen S
Medicine (Baltimore); 2023 Jun; 102(23):e33998. PubMed ID: 37335657
[TBL] [Abstract][Full Text] [Related]
18. Monitoring oral propranolol for infantile hemangiomata.
Bar J; Bar-Ilan E; Cleper R; Sprecher E; Samuelov L; Mashiah J
Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
[TBL] [Abstract][Full Text] [Related]
19. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
20. Propranolol for infantile haemangiomas and neuroglycopenic seizures.
Fusilli G; Merico G; Gurrado R; Rosa T; Acquafredda A; Cavallo L
Acta Paediatr; 2010 Dec; 99(12):1756. PubMed ID: 20726852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
